A Systematic Review of Interventions for Health Anxiety Presentations Across Diverse Chronic Illnesses
Health anxiety (HA) is associated with reduced quality of life among individuals with chronic illnesses. However, little is known about effective interventions for reducing HA in this context. This study aimed to comprehensively review the literature on interventions for the treatment of HA in chronic illness.
This study was conducted as part of a larger systematic review on HA among individuals diagnosed with a chronic illness, using literature published between January 1996 and October 2017. A total of 51 articles were selected as they reported on interventions with pre-post measures and described the impact of the intervention on HA.
The data on psychotherapy (CBT, third-wave CBT, and mindfulness), patient education, and rehabilitation programs demonstrated effectiveness in cancer and cardiac patients. Exercise interventions demonstrated effectiveness in patients with Parkinson’s disease, and medical interventions showed limited effectiveness in reducing HA in diabetes and epilepsy. Most interventions yielding significant outcomes were at least 6 to 8 weeks long.
The literature supports that a variety of interventions may be effective in reducing HA in individuals with chronic illness. Future research should test single interventions across several illnesses, as well as several interventions within a single illness to better understand how HA can be managed across chronic illnesses.
KeywordsHealth anxiety Chronic illness Interventions Systematic review Treatments
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
- 3.Taylor S, Asmundson GJG. Treating health anxiety: a cognitive behavioral approach. New York: Guilford Press; 2004.Google Scholar
- 4.American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.Google Scholar
- 6.Ministry of Health and Long Term Care. Preventing and managing chronic disease: Ontario’s framework [Internet]. 2007. Available from: http://www.health.gov.on.ca/en/pro/programs/cdpm/pdf/framework_full.pdf.
- 7.Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, et al. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study. Psychooncology. 2014;23:547–54.PubMedCrossRefPubMedCentralGoogle Scholar
- 16.Van Dessel N, Den Boeft M, van der Wouden JC, Kleinstaeuber M, Leone SS, Terluin B, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;11:CD011142.Google Scholar
- 17.Taylor S, Asmundson GJG. Hypochondriasis and health anxiety. In: Antony MM, Stein MB, editors. Oxford handbook of anxiety related disorders. Oxford: Oxford University Press; 2008.Google Scholar
- 23.Kendrick D, Kumar A, Carpenter H, Zijlstra GAR, Skelton DA, Cook JR, et al. Exercise for reducing fear of falling in older people living in the community. Cochrane Database Syst Rev. 2014;28:CD009848.Google Scholar
- 27.Berry PH, Covington EC, Dahl JL, Katz JA, Miaskowski C. Pain: current understanding of assessment, management and treatments. Glenview: American Pain Society; 2009.Google Scholar
- 44.Galasso S, Facchinetti A, Bonora BM, Mariano V, Boscari F, Cipponeri E, et al. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study. Nutr Metab Cardiovasc Dis. 2016;26:1112–9.PubMedCrossRefPubMedCentralGoogle Scholar
- 47.Hayes RP, Nakano M, Muchmore D, Schmitke J. Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system. Diabetes Technol Ther. 2007;9:89–98.PubMedCrossRefPubMedCentralGoogle Scholar
- 54.Lengacher CA, Shelton MM, Reich RR, Barta MK, Johnson-Mallard V, Moscoso MS, et al. Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2014;37:185–95.PubMedCrossRefGoogle Scholar
- 58.Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 x 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014;37:2114–22.PubMedCrossRefGoogle Scholar
- 59.Lundgren JG, Dahlstrom O, Andersson G, Jaarsma T, Kohler AK, Johansson P. The effect of guided web-based cognitive behavioral therapy on patients with depressive symptoms and heart failure: a pilot randomized controlled trial. J Med Internet Res. 2016;18:e194.PubMedPubMedCentralCrossRefGoogle Scholar
- 62.Merckaert I, Lewis F, Delevallez F, Herman S, Caillier M, Delvaux N, et al. Improving anxiety regulation in patients with breast cancer at the beginning of the survivorship period: a randomized clinical trial comparing the benefits of single-component and multiple-component group interventions. Psychooncology. 2017;26:1147–54.PubMedCrossRefGoogle Scholar
- 63.Montesinos F, Luciano C. Acceptance of relapse fears in breast cancer patients: effects of an ACT-based abridged intervention. Psicooncologia. 2016;13:7–21.Google Scholar
- 70.Rudolph B, Wünsch A, Herschbach P, Dinkel A. Cognitive-behavioral group therapy addressing fear of progression in cancer out-patients [Ambulante verhaltenstherapeutische gruppentherapie zur behandlung von progredienzangst bei krebspatienten]. Psychother Psychosom Med Psychol. 2018;68:38–43.PubMedCrossRefPubMedCentralGoogle Scholar
- 75.Vallejo-Mora MD, Carreira-Soler M, Linares-Parrado F, Olveira G, Rojo-Martinez G, Dominguez-Lopez M, et al. The calculating boluses on multiple daily injections (CBMDI) study: a randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes. J Diabetes. 2017;9:24–33.PubMedCrossRefPubMedCentralGoogle Scholar
- 76.van Beers CAJ, de Wit M, Kleijer SJ, Geelhoed-Duijvestijn PH, DeVries JH, Kramer MHH, et al. Continuous glucose monitoring in patients with type 1 diabetes and impaired awareness of hypoglycemia: also effective in patients with psychological distress? Diabetes Technol Ther. 2017.Google Scholar
- 77.van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35:2173–83.PubMedCrossRefPubMedCentralGoogle Scholar
- 83.Zijlstra GR, Van Haastregt JC, Ambergen T, Van Rossum E, Van Eijk JTM, Tennstedt SL, et al. Effects of a multicomponent cognitive behavioral group intervention on fear of falling and activity avoidance in community-dwelling older adults: results of a randomized controlled trial. J Am Geriatr Soc. 2009;57:2020–8.PubMedCrossRefGoogle Scholar
- 84.Roemer L, Erisman SM, Orsillo SM. Mindfulness and acceptance-based treatments for anxiety disorders. In: Antony MM, Stein MB, editors. Oxford handbook of anxiety related disorders. Oxford: Oxford University Press; 2008. p. 476–87.Google Scholar